This week in politics saw a mix of international tensions, health concerns for former leaders, and party infighting. From Xi Jinping’s potential military ambitions to concerns about Donald Trump’s health, here’s a recap of the top stories that made headlines.
Xi Jinping’s Ambitions for Taiwan
China hawk and founder of U.S. investment firm Hayman Capital Management, Kyle Bass, warned that Chinese President Xi Jinping might launch an invasion of Taiwan by 2024. Bass believes that Xi is determined to “bring war to the West” and that Wall Street is overlooking this possibility. Read the full article here.
Concerns Over Trump’s Health
Democratic strategist James Carville expressed concerns about former President Donald Trump‘s health amidst ongoing political stress. Carville believes that Trump’s legal battles could hinder his chances of securing the nomination for the 2024 elections. Read the full article here.
White House vs. Kevin McCarthy
The White House accused Speaker Kevin McCarthy of lying to appease far-right House Republicans who are advocating for an impeachment inquiry into President Joe Biden. The White House Counsel’s Office spokesman, Ian Sams, criticized McCarthy’s recent claims and labeled them as “plainly false.” Read the full article here.
Mike Lindell’s Predictions for Trump
MyPillow CEO Mike Lindell foresees a sweeping victory for former President Donald Trump in the 2024 elections. Lindell believes that the multiple indictments against Trump are amplifying his follower base. Read the full article here.
Chris Christie on Trump’s Debate Absence
Former Governor of New Jersey, Chris Christie, criticized former President Donald Trump for his potential absence from the forthcoming Republican debate. Christie believes that Trump’s nonattendance would symbolize a “lack of respect” towards Republican voters. Read the full article here.
For more in-depth coverage on political events, you can read more on Benzinga's politics coverage by following this link.
This illustration was generated using artificial intelligence via MidJourney.
Engineered by Benzinga Neuro, Edited by Navdeep Yadav
The GPT-4-based Benzinga Neuro content generation system exploits the extensive Benzinga Ecosystem, including native data, APIs, and more to create comprehensive and timely stories for you. Learn more.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
